Delivery Order SPE2DB20D3103-SPE2DB25FN7W1
Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $76K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,639.28 delivery order on September 17, 2025, for Sandostatin LAR Depot 20 mg kits, a specialty pharmaceutical product used in the treatment of acromegaly and neuroendocrine tumors. This competitively awarded, firm fixed-price contract represents an individual delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $21,594.51 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in the treatment of acromegaly and neuroendocrine tumors. This competitively awarded, firm fixed-price delivery order, issued on May 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in the treatment of acromegaly and neuroendocrine tumors. This firm fixed-price delivery order, valued at $48,386.59, represents a competitive award with no set-aside designation and is scheduled for completion by September 4, 2025. The work will be performed at...
- The Defense Logistics Agency awarded a $11,407.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for Sandostatin LAR Depot 20 mg kits, with an ultimate completion date of September 22, 2025. This non-competitive delivery order represents a pharmaceutical supply requirement fulfilled through AmerisourceBergen's existing contract vehicle with the DLA. The product, Sandostatin LAR Depot, is a long-acting somatostatin analog used for managing acromegaly and...
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,639.28 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Sandostatin LAR Depot 20 mg kits, with performance completion targeted for July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $10,639.28 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 20 mg kits, with a completion date of September 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a leading pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded a $12,832.80 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Sandostatin LAR Depot 30 mg kits. Scheduled for completion by September 17, 2025, this firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $38,625.42 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 20 mg kits. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, completed on May 20, 2025. Sandostatin LAR Depot is a long-acting injectable formulation of octreotide used primarily for managing acromegaly and neuroendocrine tumors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $24,528.04 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 20 mg kits, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Sandostatin LAR Depot is a long-acting somatostatin analog used in the treatment of acromegaly and neuroendocrine tumors,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sandostatin LAR Depot 20 mg kits under a firm fixed-price contract valued at $21,278.56. This is a competitive award with no set-aside designation, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and an ultimate completion date of August 13, 2025. The delivery order is a child contract under...